- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 60.73M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $3.03B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $2.76B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $9.5M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $9.5M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $623.8M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $735.6M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.59B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.52B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $2.21B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.33B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $6.88B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $6.67B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 64.02M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $15.7M |
| Capex restated | Q1 2025 · Mar 31, 2024 | $38.3M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $166.7M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.51 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.51 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $61M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$32.6M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $29.2M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $3.03B |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $3.13B |